PARIS, FRANCE: Air Liquide announced plans to acquire 70.49 per cent of LVL Medical Group share capital from the controlling shareholders at a price of €30.89 per share. This transaction, once finalized, would enable Air Liquide to gain control of LVL Medical’s French activities, for an enterprise value of €316 million.
This acquisition of a controlling stake in LVL Medical will be followed by a simplified public tender offer on the remaining LVL Medical share and subscription warrants, in accordance with applicable rules. Prior to the acquisition by Air Liquide, LVL Medical’s German activities will be acquired by the Lavorel Family, the majority shareholder.
“LVL Medical is one of the key players in home healthcare in France, recognized for its expertise, the professionalism of its teams and its service quality. Our know-how combined with that of LVL Medical, and our capacity for innovation, will enable LVL Medical to pursue its development. This acquisition is in line with Air Liquide’s external growth strategy in healthcare. Health is one of the growth drivers of the Group,” said Pascal Vinet, Vice President, Healthcare Global Operations and Member of Executive Committee, Air Liquide.
© WOC News